Practice characteristics and prescribing of cardiovascular drugs in areas with higher risk of CHD in Scotland: Cross-sectional study

International Journal for Equity in Health

Volumn 7, Issue , 2008, Pages

  McLean, Gary ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; CLOPIDOGREL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; WARFARIN;

ARTICLE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CONTROL GROUP; CONTROLLED STUDY; COST; CROSS-SECTIONAL STUDY; ETHNIC GROUP; FEMALE; HEALTH CARE SYSTEM; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; MALE; MEDICAL STAFF; POPULATION; PRESCRIPTION; REIMBURSEMENT; RISK; SCORING SYSTEM; SOUTH ASIA; UNITED KINGDOM;

EID: 48249083827     PISSN: None     EISSN: 14759276     Source Type: Journal    
DOI: 10.1186/1475-9276-7-18     Document Type: Article

References (42)

1. http://www.gro-scotland.gov.uk/grosweb/grosweb.nsf/pages/file12/ $file/03t6-4.pdf
2. CHD/Stroke Task force Report. Scottish Health Executive Department, Scottish Executive 2000
3. Cross sectional analysis of mortality by country of birth in England and Wales. S Wild PM McKiegue, BMJ 1997 314 705 710 9116545
4. What is the risk of coronary heart disease in South Asians? A review of UK research. R Bhopal, Journal of Public Health Medicine 2000 22 375 385 10.1093/pubmed/22.3.375 11077913
5. Are Indo-origin people especially susceptible to coronary heart disease? N Shaukat DP de Bono, Postgraduate Medical Journal 1994 70 315 318 8016000
6. Mortality from coronary heart disease in Asian communities in London. PM McKiegue MG Marmot, BMJ 1998 297 903 3140974
7. Ethnicity and variations in mortality from CHD. R Balarajan, Health Trends 1996 28 45 51
8. Lipids and the Primary Prevention of Coronary Heart Disease. Scottish Intercollegiate Guidelines Network, Sign Publication Number 40 1999
9. Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional survey. P Primatesta NR Poulter, BMJ 2000 321 1322 1325 11090516 10.1136/bmj.321.7272.1322
10. The inverse care law. JT Hart, Lancet 1971 1 405 12 4100731
11. Equity of access to health care services: theory and evidence from the UK. M Goddard P Smith, Soc Sci Med 2001 53 1149 1162 10.1016/S0277-9536(00) 00415-9 11556606
12. How equitable are GP prescribing rates for statins?: an ecological study in four primary care trusts in North West England. P Ward P Noyce A Leger, International Journal for equity in Health 2007 6 2 17386118 10.1186/1475-9276-6-2
13. Exploring the equity of GP practice prescribing rates for selected coronary heart disease drugs: a multiple regression analysis with proxies of healthcare need. PR Ward PR Noyce AS St Leger, International Journal for Equity in Health 2005 4 3 15701165 10.1186/1475-9276-4-3
14. Prescribing of lipid lowering drugs to South Asian patients: ecological study. MG Patel DJ Wright PS Gill, BMJ 2002 325 25 6 12098726 10.1136/bmj.325.7354.25
15. Independent report into inequalities in health. D Acheson, London: HMSO 1998
16. Equity in the NHS. Monitoring and promoting equity and secondary care. FA Majeed N Chaturvedi R Reading, BMJ 1994 308 1426 9 8019258
17. Variation in coronary artery bypass grafting, angioplasty, cataract surgery, and hip replacement rates among primary care groups in London: association with population and practice characteristics. FA Majeed J Eliahoo M Bardsley, Journal of Public Health Medicine 2002 24 21 26 10.1093/pubmed/24.1.21 11939378
18. Does Access to cardiac investigation and treatment contribute to social and ethnic differences in coronary heart disease? Whitehall II prospective cohort study. A Britton M Shipley M Marmot H Hemingway, BMJ 2004 329 318 321 15237088 10.1136/bmj.38156.690150.AE
19. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. S Gottlieb R McCarter R Vogel, New England Journal of Medicine 1998 339 489 497 10.1056/NEJM199808203390801 9709041
20. Are GP practice prescribing rates for coronary heart disease drugs equitable? A cross sectional analysis in four primary care trusts in England. P Ward P Noyce A Leger, Journal of Epidemiology and Community Health 2004 58 89 96 10.1136/jech.58.2.89
21. General practice in Gloucestershire, Avon and Somerset; explaining variations in standards. R Baker, British Journal of General Practice 1992 42 415 8 1466919
22. Provision of health clinics in relation to population need: another example of the inverse care law. S Gilliam, British Journal of General Practice 1992 42 54 6 1493005
23. The inverse care law today. G Watt, The Lancet 2002 360 252 254 10.1016/S0140-6736(02)09466-7 12133675
24. Deprivation and quality of primary care services: evidence for the persistence of the inverse care law from the UK Quality and Outcomes Framework. G McLean M Sutton B Guthrie, Journal of Epidemiology and Community Health 2006 60 917 922 10.1136/jech.2005.044628 17053278
25. Limited Dependent and Qualitative Variables in Econometrics. GS Maddala, Econometric Society Monographs No.3 Cambridge University Press: New York 1983
26. Fair Shares for All: Final Report. Scottish Health Executive Department, The National Review of Resources Allocation for the NHS in Scotland Scottish Executive 2000
27. Scottish Indices of Deprivation 2003. Social Disadvantage Research Centre, Department of Social Policy and Research Work University of Oxford 2003
28. Statement of Fees and Allowances Payable To General Medical Practitioners in Scotland From 1 April 1990. Scottish Executive Health Department, Edinburgh: Scottish Executive 1990 http://www.sfa.scot.nhs.uk/ accessed October 2005
29. Propensity score matching: an illustrative analysis of dose response. EM Foster, Medical Care 2003 41 1 1183 1192 10.1097/01.MLR.0000089629.62884.22 14515114
30. Evaluating non-randomised intervention studies. JJ Deeks J Dinnes R D'Amico AJ Sowden C Sakovitch F Song M Petticrew DG Altman, Health Technology Assessment 2003 7 27 1 173
31. General Registrar Office for Scotland. Vital events reference tables 2002 http://www.groscotland.gov.uk/files/02t1-7.pdf (accessed 2 October 2005)
32. Gender, age and deprivation differences in the primary care management of hypertension in Scotland: a cross sectional database study. E Pears PC Hannaford MW Taylor, Family Practice 2003 20 1 22 31 10.1093/fampra/20.1.22 12509366
33. Risk Factors for cardio respiratory and all cause mortality in men and women in Urban Scotland: 15-year follow up. GCM Watt CL Hart DJ Hole GD Smith CR Gillis VM Hawthorne, Scottish Medical Journal 1995 40 4 108 112 8787109
34. Scottish Health Statistics 1999. Information and Statistics Division, NHS Scotland 2000
35. Health and well-being profiles for Scottish constituencies. Public Health Institute of Scotland, NHS Scotland 2004
36. Ethnic differences in consultation rates in urban general practice. S Gilliam B Jarman P White R Law, BMJ 1989 299 953 7 2508951
37. Explaining outputs of primary health care: population and practice factors. D Baker R Klein, BMJ 1991 303 225 229 1653065
38. Derivation of a needs based capitation formula for allocating prescribing budgets to health authorities and primary care groups in England: regression analysis. N Rice P Dixon DCEF Lloyd D Roberts, BMJ 2000 320 284 8 10650026 10.1136/bmj.320.7230.284
39. Allocation of Resources to English Areas: Individual and small area determinants of morbidity and use of healthcare resources. M Sutton H Gravelle S Morris A Leyland F Windmeijer C Dibben M Muirhead, Report to the Department of Health in England. Edinburgh: Information and Statistics Division 2002
40. Practice factors that influence antibiotic prescribing in general practice in Tayside. D Steinke D Bain T McDonald P Davey, Journal of Antimicrobial Chemotherapy 2000 46 509 512 10.1093/jac/46.3.509 10980184
41. Developing prevalence-based prescribing units for analysing variations in general practitioner prescribing: a case study using statins. P Ward P Noyce A Leger, J Clin Pharm Ther 2003 28 23 29 10.1046/j.1365-2710.2003.00451.x 12605615
42. Bringing context back into epidemiology: variables and fallacies in multi-level analysis. A Diez-Roux, Am J Public Health 1998 88 216 22 9491010